Thanyakorn Chalalai Selected Research

SSR 69071

10/2021

Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thanyakorn Chalalai Research Topics

Disease

3	Inflammation (Inflammations) 07/2022 - 10/2021
2	Colitis 01/2022 - 10/2021
1	Neoplasms (Cancer) 12/2022
1	Ulcerative Colitis 01/2022
1	Hemorrhage 01/2022
1	Dysbiosis 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Carcinoma (Carcinomatosis) 10/2021

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2022 - 10/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 12/2022
1	Interleukin-9 (Interleukin 9)IBA 12/2022
1	palmidrolIBA 07/2022
1	N-acylethanolaminesIBA 07/2022
1	LipidsIBA 07/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Drinking WaterIBA 01/2022
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2022
1	Vancomycin FDA LinkGeneric 01/2022
1	sairei-toIBA 01/2022
1	Dextran SulfateIBA 10/2021
1	LipopolysaccharidesIBA 10/2021
1	SSR 69071IBA 10/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2021
1	Secretory Leukocyte Peptidase InhibitorIBA 10/2021

Therapy/Procedure

1	Oral Administration 01/2022